Connor, Clark & Lunn Investment Management (CC&L)
BCAB icon

Connor, Clark & Lunn Investment Management (CC&L)’s BioAtla BCAB Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,351
Closed -$161K – 1441
2024
Q2 		$161K Sell
2,351
-2,328
-50% -$277K ﹤0.01% 1282
2024
Q1 		$805K Buy
4,679
+1,996
+74% +$248K ﹤0.01% 948
2023
Q4 		$330K Sell
2,683
-208
-7% -$18K ﹤0.01% 1150
2023
Q3 		$246K Sell
2,891
-82
-3% -$10.5K ﹤0.01% 1194
2023
Q2 		$446K Buy
2,973
+2,001
+206% +$344K ﹤0.01% 1018
2023
Q1 		$130K Buy
+972
New +$175K ﹤0.01% 1134

Other funds holding BCAB

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s BCAB Position: Q3 2024 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of BioAtla (BCAB) in Q3 2024, closing a stake of 2,351 shares — an estimated $161K sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in BCAB in Q1 2023 and held it in 6 quarters. The position peaked at $805K in Q1 2024. 63 funds tracked by Wall St. Rank hold BCAB as of Q3 2024.

  • Connor, Clark & Lunn Investment Management (CC&L) reported no remaining BioAtla position as of Q3 2024 after selling out during the quarter.
  • Connor, Clark & Lunn Investment Management (CC&L) sold 2,351 BioAtla shares in Q3 2024, an estimated $161K.
  • Connor, Clark & Lunn Investment Management (CC&L) first reported a position in BioAtla in Q1 2023 and held it in 6 quarters.
  • Connor, Clark & Lunn Investment Management (CC&L)'s BioAtla position peaked at $805K in Q1 2024.
  • 63 funds tracked by Wall St. Rank held BioAtla as of Q3 2024.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q3 2024, filed 8 Nov 2024.